• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人原发免疫性血小板减少症皮肤黏膜及内脏出血的危险因素:日本全国性研究。

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.

机构信息

Department of Blood Transfusion and Cell Therapy, Ehime University Hospital, Toon, Ehime, Japan.

Center for Basic Medical Research, International University of Health and Welfare, Otawara, Tochigi, Japan.

出版信息

Blood Adv. 2020 Apr 28;4(8):1648-1655. doi: 10.1182/bloodadvances.2020001446.

DOI:10.1182/bloodadvances.2020001446
PMID:32320469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7189281/
Abstract

Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19 415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 × 109/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age ≥60 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P < .001), platelet count <10 × 109/L (OR, 2.96; 95% CI, 2.11-4.15; P < .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.

摘要

原发性免疫性血小板减少症 (ITP) 的出血表现范围从皮肤瘀点到危及生命的颅内出血 (ICH)。然而,这些不同的出血表现与 ITP 中的血小板计数之间的关系仍未得到很好的描述。利用日本 2005 年至 2014 年 (10 年) 期间的 ITP 患者全国性数据库,我们分析了 19415 例新诊断为 ITP 的成年患者,其中包括 222 例 ICH 患者。皮肤紫癜的发生率为 64.8%,并且随着血小板减少呈线性增加,没有特定的血小板计数阈值。相比之下,黏膜出血(鼻出血和牙龈出血)和器官出血(黑便、血尿和 ICH)随着血小板计数在 10 到 15×109/L 的阈值呈指数增加。年龄与皮肤和黏膜出血的相关性远弱于血小板计数。然而,器官出血的发生率在 60 岁以上呈指数增加。多变量分析显示,黏膜出血的存在是发生黑便和血尿的危险因素,但不是 ICH 的危险因素。ICH 的发生率为 1.1%,ICH 的危险因素是年龄≥60 岁(比值比 [OR],3.09;95%置信区间 [CI],2.13-4.47;P<0.001),血小板计数<10×109/L(OR,2.96;95% CI,2.11-4.15;P<0.001),以及血尿的存在(OR,1.56;95% CI,1.04-2.35;P=0.033)。ICH 与血小板计数之间的关系随年龄而变化。对 ITP 出血危险因素的这项大规模分析揭示了新诊断为 ITP 的成年患者皮肤、黏膜和器官出血的明显特征,从而表明那些有发生严重器官出血高风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/7189281/5532c5070a86/advancesADV2020001446absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/7189281/5532c5070a86/advancesADV2020001446absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/7189281/5532c5070a86/advancesADV2020001446absf1.jpg

相似文献

1
Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.成人原发免疫性血小板减少症皮肤黏膜及内脏出血的危险因素:日本全国性研究。
Blood Adv. 2020 Apr 28;4(8):1648-1655. doi: 10.1182/bloodadvances.2020001446.
2
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.新诊断的成人免疫性血小板减少症患者出血的风险因素,包括血小板计数阈值。
J Thromb Haemost. 2018 Sep;16(9):1830-1842. doi: 10.1111/jth.14227. Epub 2018 Aug 12.
3
Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.原发性免疫性血小板减少症中的危及生命的出血事件:一项对169例住院患者的单中心回顾性研究。
Ann Hematol. 2017 Nov;96(11):1915-1920. doi: 10.1007/s00277-017-3095-6. Epub 2017 Aug 14.
4
Intracranial hemorrhage in primary immune thrombocytopenia (ITP): 20 years' experience in pediatrics.原发性免疫性血小板减少症(ITP)患者的颅内出血:儿科 20 年经验。
Eur J Pediatr. 2021 May;180(5):1545-1552. doi: 10.1007/s00431-020-03923-x. Epub 2021 Jan 15.
5
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.成人和儿童原发性免疫性血小板减少症的严重出血事件:一项系统评价。
J Thromb Haemost. 2015 Mar;13(3):457-64. doi: 10.1111/jth.12813. Epub 2015 Jan 14.
6
Bleeding complications in immune thrombocytopenia.免疫性血小板减少症的出血并发症
Hematology Am Soc Hematol Educ Program. 2015;2015:237-42. doi: 10.1182/asheducation-2015.1.237.
7
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.年龄<60 岁的免疫性血小板减少症患者颅内出血的风险分层和结局。
Platelets. 2021 Jul 4;32(5):633-641. doi: 10.1080/09537104.2020.1786042. Epub 2020 Jul 2.
8
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.儿童免疫性血小板减少症(ITP)并发颅内出血(ICH):40 例研究。
Blood. 2009 Nov 26;114(23):4777-83. doi: 10.1182/blood-2009-04-215525. Epub 2009 Sep 18.
9
Clinical variations between three different causes of thrombocytopenia.三种不同原因导致血小板减少症的临床差异。
Niger J Clin Pract. 2021 Jan;24(1):17-20. doi: 10.4103/njcp.njcp_84_20.
10
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.儿童和青少年免疫性血小板减少症的隐匿性出血:与实验室参数和健康相关生活质量的关系。
J Thromb Thrombolysis. 2020 Aug;50(2):258-266. doi: 10.1007/s11239-020-02036-4.

引用本文的文献

1
Dose-optimised recombinant human thrombopoietin eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study).剂量优化的重组人血小板生成素艾曲泊帕治疗免疫性血小板减少症患者:一项多中心随机对照试验(TE-ITP研究)
EClinicalMedicine. 2025 Aug 21;87:103459. doi: 10.1016/j.eclinm.2025.103459. eCollection 2025 Sep.
2
Immune thrombocytopenia in adolescents and young adults.青少年和青年的免疫性血小板减少症
Front Med (Lausanne). 2025 Mar 26;12:1553936. doi: 10.3389/fmed.2025.1553936. eCollection 2025.
3
Impact of platelet transfusion and bleeding risk stratification in patients with immune thrombocytopenia before procedures.

本文引用的文献

1
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
2
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
3
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
免疫性血小板减少症患者术前血小板输注及出血风险分层的影响
Sci Rep. 2025 Feb 12;15(1):5174. doi: 10.1038/s41598-025-89419-w.
4
Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Immune Thrombocytopenia.免疫性血小板减少症患者血栓形成的危险因素分析及预测模型的建立
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296241301398. doi: 10.1177/10760296241301398.
5
Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.慢性原发性免疫性血小板减少症青少年及青年患者长期随访中的持续缓解情况
Blood Adv. 2024 Dec 24;8(24):6183-6194. doi: 10.1182/bloodadvances.2024014381.
6
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南,2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
7
How we treat primary immune thrombocytopenia in adults.成人原发免疫性血小板减少症的治疗方法。
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
8
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.COVID-19 疫苗接种相关免疫性血小板减少性紫癜:一项系统评价。
Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30.
9
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.开发和验证 ITP 中 ICH 死亡率预测模型:一项全国代表性多中心研究。
Blood Adv. 2022 Jul 26;6(14):4320-4329. doi: 10.1182/bloodadvances.2022007226.
10
Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline.免疫性血小板减少症的牙槽手术;系统评价与机构指南
TH Open. 2021 Sep 9;5(4):e489-e502. doi: 10.1055/a-1641-7770. eCollection 2021 Oct.
新诊断的成人免疫性血小板减少症患者出血的风险因素,包括血小板计数阈值。
J Thromb Haemost. 2018 Sep;16(9):1830-1842. doi: 10.1111/jth.14227. Epub 2018 Aug 12.
4
Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.原发性免疫性血小板减少症中的危及生命的出血事件:一项对169例住院患者的单中心回顾性研究。
Ann Hematol. 2017 Nov;96(11):1915-1920. doi: 10.1007/s00277-017-3095-6. Epub 2017 Aug 14.
5
Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases.免疫性血小板减少症成人颅内出血的相关危险因素:一项27例病例的研究。
Am J Hematol. 2016 Dec;91(12):E499-E501. doi: 10.1002/ajh.24529. Epub 2016 Aug 22.
6
Intracranial Hemorrhage in Patients with Hematologic Disorders: Prevalence and Predictive Factors.血液系统疾病患者的颅内出血:患病率及预测因素
J Med Assoc Thai. 2016 Jan;99(1):15-24.
7
Bleeding complications in immune thrombocytopenia.免疫性血小板减少症的出血并发症
Hematology Am Soc Hematol Educ Program. 2015;2015:237-42. doi: 10.1182/asheducation-2015.1.237.
8
Presence of Essential Hypertension or Diabetes Mellitus Is a Predictor of Intracranial Bleeding in Elderly Patients: A Study of 108 Patients with Isolated Thrombocytopenia from a Single Reference Center.原发性高血压或糖尿病的存在是老年患者颅内出血的一个预测因素:来自单一参考中心的108例孤立性血小板减少症患者的研究。
Turk J Haematol. 2015 Jun;32(2):158-62. doi: 10.4274/tjh.2013.0161.
9
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.成人和儿童原发性免疫性血小板减少症的严重出血事件:一项系统评价。
J Thromb Haemost. 2015 Mar;13(3):457-64. doi: 10.1111/jth.12813. Epub 2015 Jan 14.
10
Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.中国免疫性血小板减少症儿童的严重出血
J Pediatr Hematol Oncol. 2015 Apr;37(3):e158-61. doi: 10.1097/MPH.0000000000000292.